Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shailendra Verma

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Critical Reviews in Oncology/Hematology|April 22, 2011
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumorsArlene Chan, Shailendra Verma, Sibylle Loibl, et al.
Breast Cancer Research and Treatment|April 30, 2008
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effectsHeather-Jane Au, Kamran Golmohammadi, Tallal Younis, et al.
Hematology (Amsterdam, Netherlands)|November 7, 2023
Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in IndiaTulika Seth, Kapil Garg, Prakas Kumar Mandal, et al.
Breast (Edinburgh, Scotland)|June 1, 2013
Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.
Patient Education and Counseling|June 11, 2013
Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
Surgical Oncology|March 17, 2016
A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapyJoel Werier, Xiaomei Yao, Jean-Michel Caudrelier, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid studyJohanna Mäenpää, Ioannis Varthalitis, Frans Erdkamp, et al.
Cancer Treatment Reviews|February 25, 2020
An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomasXiaomei Yao, Michelle Ghert, Brendan C Dickson, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2009
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancerSusan F Dent, Stan Gertler, Shailendra Verma, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Critical Reviews in Oncology/Hematology|April 22, 2011
Reporting of myelotoxicity associated with emerging regimens for the treatment of selected solid tumorsArlene Chan, Shailendra Verma, Sibylle Loibl, et al.
Breast Cancer Research and Treatment|April 30, 2008
Cost-effectiveness analysis of adjuvant docetaxel, doxorubicin, and cyclophosphamide (TAC) for node-positive breast cancer: modeling the downstream effectsHeather-Jane Au, Kamran Golmohammadi, Tallal Younis, et al.
Hematology (Amsterdam, Netherlands)|November 7, 2023
Cost-effectiveness analysis of low-dose prophylaxis versus on-demand treatment for moderate-to-severe hemophilia A in IndiaTulika Seth, Kapil Garg, Prakas Kumar Mandal, et al.
Breast (Edinburgh, Scotland)|June 1, 2013
Information for decision making by post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.
Patient Education and Counseling|June 11, 2013
Information needs of post-menopausal women with hormone receptor positive early-stage breast cancer considering adjuvant endocrine therapyDeb Feldman-Stewart, Yolanda Madarnas, Mihaela Mates, et al.
Clinical Breast Cancer|September 3, 2018
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerVered Stearns, Adam M Brufsky, Shailendra Verma, et al.
Surgical Oncology|March 17, 2016
A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapyJoel Werier, Xiaomei Yao, Jean-Michel Caudrelier, et al.
Breast (Edinburgh, Scotland)|January 24, 2016
The use of granulocyte colony stimulating factor (G-CSF) and management of chemotherapy delivery during adjuvant treatment for early-stage breast cancer--further observations from the IMPACT solid studyJohanna Mäenpää, Ioannis Varthalitis, Frans Erdkamp, et al.
Cancer Treatment Reviews|February 25, 2020
An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomasXiaomei Yao, Michelle Ghert, Brendan C Dickson, et al.
Cancer Chemotherapy and Pharmacology|July 14, 2009
A phase II study of biweekly pemetrexed and gemcitabine in patients with metastatic breast cancerSusan F Dent, Stan Gertler, Shailendra Verma, et al.
Pageof 6